Description: A companion structure to 9E5D, this 1.35 Å resolution crystal captures KRAS G12D in complex with Compound 23, an alternative inhibitor from the same drug discovery campaign. Together with 9E5D, it maps the SAR landscape that enabled optimization of orally bioavailable KRAS G12D inhibitors for oncology.